Fentanyl Citrate
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | generic | 7 | SUPPLYING |
| Civica, Inc | unknown | 2 | SUPPLYING |
| Phlow Corporation | unknown | 1 | EXITED 2028 |
Shortages, recalls, and registration changes attached to this drug concept.
Fentanyl Citrate Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction, Pediatric.
Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548). — Recalling firm: West-Ward Pharmaceutical Corp. — Nationwide
Failed Impurities/Degradation Specifications; 12 month stability testing. — Recalling firm: West-Ward Pharmaceutical Corporation — Nationwide
